Author

Maria Adelaide Pessi

Observed names: A. Pessi, Adelaide Pessi, Adelaide, Pessi Maria, M A Pessi, M Adelaide Pessi, M. A. Pessi, M. Adelaide Pessi, M.A. Pessi, Pessi Maria Adelaide, Pessi, Maria Adelaide

Institution: MultiMedica

Observed institutions: Ospedale San Paolo, Azienda Ospedaliera Ospedale San Carlo Borromeo, MultiMedica, Ospedale Papa Giovanni XXIII, Gruppo Italiano per lo Studio dei Carcinomi dell’Apparato Digerente, Ospedale San Giuseppe, Fondazione IRCCS Istituto Nazionale dei Tumori

OpenAlex ID: A5089015373

Colon cancer

2010 · Roberto Labianca, Giordano D. Beretta, et al. · Critical Reviews in Oncology/Hematology · 409

A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin

2017 · P. Bossi, D. Cortinovis, et al. · Annals of Oncology · 87

PDF

A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)

1999 · S Cascinu, R R Silva, et al. · British Journal of Cancer · 82

PDF

Treatment of Colorectal Cancer

1997 · Roberto Labianca, Maria Adelaide Pessi, et al. · Drugs · 69

Patient Dignity Inventory (PDI) Questionnaire: The Validation Study in Italian Patients with Solid and Hematological Cancers on Active Oncological Treatments

2012 · Carla Ida Ripamonti, Loredana Buonaccorso, et al. · Tumori Journal · 62

Targeted therapy-induced diarrhea: A review of the literature

2013 · M.A. Pessi, N. Zilembo, et al. · Critical Reviews in Oncology/Hematology · 57

Hope Herth Index (HHI): A Validation Study in Italian Patients with Solid and Hematological Malignancies on Active Cancer Treatment

2012 · Carla Ida Ripamonti, Loredana Buonaccorso, et al. · Tumori Journal · 53

Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase II study of the Italian Group for the Study of Gastrointestinal Tract Carcinomas (GISCAD)

2002 · S. Cascinu, F. Graziano, et al. · Annals of Oncology · 52

PDF

Is it possible to encourage hope in non-advanced cancer patients? We must try

2015 · C.I. Ripamonti, G. Miccinesi, et al. · Annals of Oncology · 42

The Edmonton Symptom Assessment System (ESAS) as a screening tool for depression and anxiety in non-advanced patients with solid or haematological malignancies on cure or follow-up

2013 · Carla I. Ripamonti, Elena Bandieri, et al. · Supportive Care in Cancer · 42

Efficacy and tolerability of medical ozone gas insufflations in patients with osteonecrosis of the jaw treated with bisphosphonates—Preliminary data

2012 · C.I. Ripamonti, M. Maniezzo, et al. · Journal of bone oncology · 40

PDF

A combination of a fixed dose rate infusion of gemcitabine associated to a bolus 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)

2000 · S. Cascinu, L. Frontini, et al. · Annals of Oncology · 34

Colorectal cancer: screening

2005 · R. Labianca, G.D. Beretta, et al. · Annals of Oncology · 31

Evaluation of factors influencing 5-fluorouracil-induced diarrhea in colorectal cancer patients

1997 · S. Cascinu, S. Barni, et al. · Supportive Care in Cancer · 30

Speckle-Tracking Echocardiography for Cardioncological Evaluation in Bevacizumab-Treated Colorectal Cancer Patients

2020 · Andrea Sonaglioni, Adriana Albini, et al. · Cardiovascular Toxicology · 29

Supportive Care in Cancer Unit at the National Cancer Institute of Milan

2012 · Ripamonti Carla Ida, Pessi Maria Adelaide, et al. · Current Opinion in Oncology · 29

System of belief inventory (SBI-15R): a validation study in Italian cancer patients on oncological, rehabilitation, psychological and supportive care settings.

2010 · Carla Ripamonti, Claudia Borreani, et al. · PubMed · 27

Colorectal Cancer

2001 · Roberto F. Labianca, Giordano D. Beretta, et al. · Drugs · 27

Adjuvant treatment of colorectal cancer

2004 · Giordano D. Beretta, L. Milesi, et al. · Surgical Oncology · 19

Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: A randomized study

2000 · A. Sobrero, A. Zaniboni, et al. · Annals of Oncology · 17

PDF

The development of clinical research in CRC

2005 · R. Labianca, G.D. Beretta, et al. · Annals of Oncology · 15

Modulated 5-Fluorouracil (5-FU) Regimens in Advanced Colorectal Cancer: A Critical Review of Comparative Studies

1996 · R. Labianca, A. Pessi, et al. · European Journal of Cancer · 15

The role of adjuvant chemotherapy in colon cancer

2007 · R. Labianca, L. Milesi, et al. · Surgical Oncology · 14

New drugs and combinations in the palliative treatment of colon and rectal cancer

2001 · G.D. Beretta, M.A. Pessi, et al. · European Journal of Surgical Oncology · 13

Treatment of Osteonecrosis of the Jaw (ONJ) by Medical Ozone Gas Insufflation. A Case Report

2012 · Carla Ida Ripamonti, Massimo Maniezzo, et al. · Tumori Journal · 12

Works count: 58

Citation count: 1,393

H-index: 19

I10-index: 27